Tandem Diabetes Care Property, Plant, and Equipment 2012-2025 | TNDM
Tandem Diabetes Care property, plant, and equipment from 2012 to 2025. Property, plant, and equipment can be defined as the sum of all net property, plant & Equipment fields. Where companies do not report a break down of plant, property, & equipment, the value is entered in this field alone.
| Tandem Diabetes Care Annual Property, Plant, and Equipment (Millions of US $) |
|
|---|---|
| 2024 | $78 |
| 2023 | $77 |
| 2022 | $69 |
| 2021 | $50 |
| 2020 | $50 |
| 2019 | $33 |
| 2018 | $17 |
| 2017 | $20 |
| 2016 | $18 |
| 2015 | $16 |
| 2014 | $13 |
| 2013 | $10 |
| 2012 | $9 |
| 2011 | $4 |
| Tandem Diabetes Care Quarterly Property, Plant, and Equipment (Millions of US $) |
|
|---|---|
| 2025-03-31 | $79 |
| 2024-12-31 | $78 |
| 2024-09-30 | $81 |
| 2024-06-30 | $79 |
| 2024-03-31 | $78 |
| 2023-12-31 | $77 |
| 2023-09-30 | $76 |
| 2023-06-30 | $74 |
| 2023-03-31 | $75 |
| 2022-12-31 | $69 |
| 2022-09-30 | $73 |
| 2022-06-30 | $59 |
| 2022-03-31 | $50 |
| 2021-12-31 | $50 |
| 2021-09-30 | $50 |
| 2021-06-30 | $49 |
| 2021-03-31 | $50 |
| 2020-12-31 | $50 |
| 2020-09-30 | $49 |
| 2020-06-30 | $44 |
| 2020-03-31 | $38 |
| 2019-12-31 | $33 |
| 2019-09-30 | $28 |
| 2019-06-30 | $23 |
| 2019-03-31 | $17 |
| 2018-12-31 | $17 |
| 2018-09-30 | $18 |
| 2018-06-30 | $18 |
| 2018-03-31 | $19 |
| 2017-12-31 | $20 |
| 2017-09-30 | $20 |
| 2017-06-30 | $22 |
| 2017-03-31 | $21 |
| 2016-12-31 | $18 |
| 2016-09-30 | $17 |
| 2016-06-30 | $16 |
| 2016-03-31 | $16 |
| 2015-12-31 | $16 |
| 2015-09-30 | $15 |
| 2015-06-30 | $14 |
| 2015-03-31 | $13 |
| 2014-12-31 | $13 |
| 2014-09-30 | $12 |
| 2014-06-30 | $12 |
| 2014-03-31 | $11 |
| 2013-12-31 | $10 |
| 2013-09-30 | $10 |
| 2013-06-30 | $9 |
| 2013-03-31 | |
| 2012-12-31 | |
| 2012-09-30 | |
| 2012-06-30 | |
| 2011-12-31 | $4 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $1.294B | $0.940B |
| Tandem Diabetes Care, Inc. designs, develops and markets products for people with insulin-dependent diabetes. The company's flagship product, the t:slim X2 Insulin Delivery System, or t:slim X2, is based on its proprietary technology platform. Per the company, t:slim X2 is the smallest durable insulin pump available and is also the only available pump capable of remote feature updates.Tandem Diabetes also offers t:flex insulin delivery system which includes t:flex pump, its 480-unit disposable insulin cartridge, an infusion set, t:lock cartridge and infusion set products, various pump accessories along with t:slim X2 with G5 integration. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Intuitive Surgical (ISRG) | United States | $186.962B | 81.89 |
| Thermo Fisher Scientific (TMO) | United States | $155.018B | 18.75 |
| Edwards Lifesciences (EW) | United States | $45.151B | 29.60 |
| Alcon (ALC) | Switzerland | $43.193B | 29.19 |
| IDEXX Laboratories (IDXX) | United States | $42.656B | 49.02 |
| DexCom (DXCM) | United States | $33.204B | 51.32 |
| IQVIA Holdings (IQV) | United States | $27.457B | 15.38 |
| Mettler-Toledo (MTD) | United States | $24.791B | 29.48 |
| STERIS (STE) | Ireland | $23.645B | 26.04 |
| Waters (WAT) | United States | $20.829B | 29.39 |
| SONOVA HOLDING (SONVY) | Switzerland | $17.814B | 0.00 |
| Hologic (HOLX) | United States | $14.322B | 15.56 |
| Sysmex ADR (SSMXY) | Japan | $10.695B | 30.34 |
| Penumbra (PEN) | United States | $9.806B | 76.97 |
| Masimo (MASI) | United States | $9.179B | 33.86 |
| Globus Medical (GMED) | United States | $7.878B | 18.77 |
| Glaukos (GKOS) | United States | $5.675B | 0.00 |
| Teleflex (TFX) | United States | $5.265B | 8.69 |
| TransMedics (TMDX) | United States | $4.349B | 94.54 |
| Integer Holdings (ITGR) | United States | $4.215B | 22.08 |
| PROCEPT BioRobotics (PRCT) | United States | $3.221B | 0.00 |
| LivaNova (LIVN) | United Kingdom | $2.501B | 14.89 |
| Nihon Kohden (NHNKY) | Japan | $2.156B | 24.73 |
| Veracyte (VCYT) | United States | $2.071B | 29.07 |
| Elekta AB (EKTAY) | Sweden | $1.965B | 17.67 |
| Alphatec Holdings (ATEC) | United States | $1.643B | 0.00 |
| Artivion (AORT) | United States | $1.307B | 122.40 |
| Pulse Biosciences (PLSE) | United States | $1.030B | 0.00 |
| OPKO Health (OPK) | United States | $1.007B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $0.922B | 4.91 |
| IRadimed (IRMD) | United States | $0.768B | 38.97 |
| SiBone (SIBN) | United States | $0.764B | 0.00 |
| Beta Bionics (BBNX) | United States | $0.640B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.567B | 8.83 |
| RxSight (RXST) | United States | $0.536B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.535B | 12.53 |
| OrthoPediatrics (KIDS) | United States | $0.524B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.485B | 0.00 |
| AxoGen (AXGN) | United States | $0.467B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.458B | 12.18 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.426B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.415B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.375B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.366B | 0.00 |
| NeuroPace (NPCE) | United States | $0.347B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.329B | 0.00 |
| 908 Devices (MASS) | United States | $0.243B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.240B | 14.53 |
| Neuronetics (STIM) | United States | $0.225B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.221B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.218B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.211B | 0.00 |
| Inogen (INGN) | United States | $0.191B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.168B | 0.00 |
| CVRx (CVRX) | United States | $0.152B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.150B | 0.00 |
| LENSAR (LNSR) | United States | $0.147B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.143B | 0.00 |
| Accuray (ARAY) | United States | $0.138B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.126B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.111B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.102B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.089B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.079B | 48.00 |
| EnVVeno Medical (NVNO) | United States | $0.074B | 0.00 |
| InspireMD (NSPR) | United States | $0.069B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.066B | 0.00 |
| Hyperfine (HYPR) | United States | $0.056B | 0.00 |
| Spectral AI (MDAI) | United States | $0.055B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.047B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.044B | 0.00 | |
| Precision Optics (POCI) | United States | $0.035B | 0.00 |
| DarioHealth (DRIO) | United States | $0.031B | 0.00 |
| Envoy Medical (COCH) | United States | $0.031B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.020B | 0.00 |
| NexGel (NXGL) | United States | $0.018B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.011B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.011B | 0.00 |
| PAVmed (PAVM) | United States | $0.011B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.008B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.007B | 0.00 |
| Tenon Medical (TNON) | United States | $0.007B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.006B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.005B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.004B | 0.00 |
| Venus Concept (VERO) | Canada | $0.003B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.003B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.002B | 0.00 |
| Avinger (AVGR) | United States | $0.002B | 0.00 |
| Nuwellis (NUWE) | United States | $0.001B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.000B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $0.000B | 15.85 |